Efficacy Study of Vemurafenib in Children With Recurrent or Progressive BRAF V600E - or BRAF InsT -Mutant Brain Tumors: PNOC002

Theodore Nicolaides, Raoull Hoogendijk, Marie Jaeger-Krause, Girish Dhall, Stewart Goldman, Amar Gajjar, Lindsay Kilburn, Sarah Leary, Jane Minturn, Nicholas Whipple, Divya Ramakrishnan, Janel Long-Boyle, Mariam Aboian, Michael Prados, Annette M. Molinaro, Sabine Mueller

Open source

DOI: 10.1200/po-26-00558
Published: 2026-09
Container: JCO Precision Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/po-26-00558,
  title = {Efficacy Study of Vemurafenib in Children With Recurrent or Progressive BRAF
                    <sup>V600E</sup>
                    - or BRAF
                    <sup>InsT</sup>
                    -Mutant Brain Tumors: PNOC002},
  author = {Theodore Nicolaides and Raoull Hoogendijk and Marie Jaeger-Krause and Girish Dhall and Stewart Goldman and Amar Gajjar and Lindsay Kilburn and Sarah Leary and Jane Minturn and Nicholas Whipple and Divya Ramakrishnan and Janel Long-Boyle and Mariam Aboian and Michael Prados and Annette M. Molinaro and Sabine Mueller},
  year = {2026},
  journal = {JCO Precision Oncology},
  doi = {10.1200/po-26-00558},
  url = {https://doi.org/10.1200/po-26-00558}
}

RIS

TY  - JOUR
TI  - Efficacy Study of Vemurafenib in Children With Recurrent or Progressive BRAF
                    <sup>V600E</sup>
                    - or BRAF
                    <sup>InsT</sup>
                    -Mutant Brain Tumors: PNOC002
AU  - Theodore Nicolaides
AU  - Raoull Hoogendijk
AU  - Marie Jaeger-Krause
AU  - Girish Dhall
AU  - Stewart Goldman
AU  - Amar Gajjar
AU  - Lindsay Kilburn
AU  - Sarah Leary
AU  - Jane Minturn
AU  - Nicholas Whipple
AU  - Divya Ramakrishnan
AU  - Janel Long-Boyle
AU  - Mariam Aboian
AU  - Michael Prados
AU  - Annette M. Molinaro
AU  - Sabine Mueller
PY  - 2026
JO  - JCO Precision Oncology
DO  - 10.1200/po-26-00558
UR  - https://doi.org/10.1200/po-26-00558
ER  -

APA

Nicolaides, T., Hoogendijk, R., Jaeger-Krause, M., Dhall, G., Goldman, S., Gajjar, A., Kilburn, L., Leary, S., Minturn, J., Whipple, N., Ramakrishnan, D., Long-Boyle, J., Aboian, M., Prados, M., Molinaro, A. M., & Mueller, S. (2026). Efficacy Study of Vemurafenib in Children With Recurrent or Progressive BRAF V600E - or BRAF InsT -Mutant Brain Tumors: PNOC002. JCO Precision Oncology. https://doi.org/10.1200/po-26-00558

Source records

crossref · retrieved 2026-09-25T14:18:40.210Z

Efficacy Study of Vemurafenib in Children With Recurrent or Progressive BRAF <sup>V600E</sup> - or BRAF <sup>InsT</sup> -Mutant Brain Tumors: PNOC002

Credibility signals

Cite this work

BibTeX

RIS

APA

Source records